Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Risk adjusted net present value: What is the current valuation of Teva Pharmaceutical Industries's Olanzapine ER?
Olanzapine ER is a small molecule commercialized by Teva Pharmaceutical Industries, with a leading Phase III program in Schizophrenia. According...
Risk adjusted net present value: What is the current valuation of Teva Pharmaceutical Industries's Olanzapine ER?
Olanzapine ER is a small molecule commercialized by Teva Pharmaceutical Industries, with a leading Phase III program in Schizophrenia. According...
Olanzapine ER by Teva Pharmaceutical Industries for Schizophrenia: Likelihood of Approval
Olanzapine ER is under clinical development by Teva Pharmaceutical Industries and currently in Phase III for Schizophrenia. According to GlobalData,...